WVE Q3 2017 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$676,000+72.4% YoY

Gross Profit

-$19M-2872.9% margin

Operating Income

-$27M-3992.9% margin

Net Income

-$26M-3866.1% margin

EPS (Diluted)

$-0.94

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$29M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$202M

Total Liabilities

$36M

Stockholders' Equity

$166M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$676,000	$392,000	+72.4%
Gross Profit	-$19M	-$13M	-46.1%
Operating Income	-$27M	-$17M	-56.6%
Net Income	-$26M	-$18M	-49.0%